THE MISSION
Pharos optimizes surgical outcomes through its innovative laser tissue soldering technology, featuring a patented fluorescent paste that guides and enhances tissue bonding. By using fluorescence to precisely control laser energy in real-time, Pharos enables stronger, more reliable closures with minimal tissue damage and reduced risk of complications. Ideal for internal soft tissues where sutures and staples can cause infections, inflammation, and delayed healing, the technology is compatible with minimally invasive procedures and integrates seamlessly with existing surgical robots to further enhance precision and speed. This approach not only shortens procedural time but also elevates the standards for patient care and recovery.
"We take great pride in the growth we’ve achieved as a team, both in terms of individual development and our collective ability to collaborate more effectively. This progress has strengthened our cohesion, enhanced our skill sets, and equipped us to tackle new challenges with greater confidence and efficiency."
THE TEAM
Oscar Cipolato (PhD) - CEO | Charlotte Meyer (PhD) - Co-founder | Benjamin Suter (PhD) - Co-founder |
 | | |
 |  |  |
SUSTAINABLE DEVELOPMENT GOALS
 |
GET INVOLVED
We would be most grateful for any help or feedback you are willing to provide. This is especially true if you are a healthcare professional, medical device regulatory expert, or involved in the surgical robotic industry.
Comments